Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease

References

• Sanchez, A., Geisbert, T.W., and Feldmann, H.. Fields virology. 2007, Lippincott Williams & Wilkins, Philadelphia, U.S p. 1409-1448.
   Google Scholar
• Kuhn JH. Guide to the correct use of filoviral nomenclature. Curr Top Microbiol Immunol. 2017;411:447–460.
   PubMed Web of Science ®Google Scholar
• Goldstein T, Anthony SJ, Gbakima A, et al. The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses. Nat Microbiol. 2018;3(10):1084-1089.
   Web of Science ®Google Scholar
• Team WER, Agua-Agum J, Allegranzi B, et al. After Ebola in West Africa–unpredictable risks, preventable epidemics. N Engl J Med. 2016;375(6):587–596.
   PubMed Web of Science ®Google Scholar
• Maurice J. Expert panel slams WHO’s poor showing against Ebola. Lancet. 2015;386(9990):e1.
   PubMed Web of Science ®Google Scholar
• CDC. Ebola virus disease distribution map: cases of Ebola virus disease in Africa Since 1976. 2018 [cited 2018 Dec 19]. Available from: https://www.cdc.gov/vhf/ebola/history/distribution-map.html.
   Google Scholar
• WHO. WHO ebola virus factsheet. 2018 [cited 2018 Aug 23]. Available from: http://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease.
   Google Scholar
• Fitchett JR, Lichtman A, Soyode DT, et al. Ebola research funding: a systematic analysis, 1997-2015. J Glob Health. 2016;6(2):020703.
   PubMed Web of Science ®Google Scholar
• Ippolito G, Lanini S, Brouqui P, et al. Ebola: missed opportunities for Europe-Africa research. Lancet Infect Dis. 2015;15(11):1254–1255.
   PubMed Web of Science ®Google Scholar
• Pollock NR, Wonderly B. Evaluating novel diagnostics in an outbreak setting: lessons learned from Ebola. J Clin Microbiol. 2017;55(5):1255–1261.
   PubMed Web of Science ®Google Scholar
• Muyembe-Tamfum JJ, Mulangu S, Masumu J, et al. Ebola virus outbreaks in Africa: past and present Onderstepoort. J Vet Res. 2012;79(2):451.
   Web of Science ®Google Scholar
• Marí Saéz A, Weiss S, Nowak K, et al. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol Med. 2015;7(1):17–23.
   PubMed Web of Science ®Google Scholar
• Swanepoel R, Leman PA, Burt FJ, et al. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis. 1996;2(4):321–325.
   PubMed Web of Science ®Google Scholar
• Olival KJ, Hayman DTS. Filoviruses in bats: current knowledge and future directions. Viruses. 2014;6(4):1759–1788.
   PubMed Web of Science ®Google Scholar
• Leroy EM, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus. Nature. 2005;438(7068):575–576.
   PubMed Web of Science ®Google Scholar
• Ogawa H, Miyamoto H, Nakayama E, et al. Seroepidemiological prevalence of multiple species of filoviruses in fruit bats (Eidolon helvum) migrating in Africa. J Infect Dis. 2015;212(Suppl 2):S101–8.
   PubMed Web of Science ®Google Scholar
• Laing ED, Mendenhall IH, Linster M, et al. Serologic evidence of fruit bat exposure to filoviruses, Singapore, 2011-2016. Emerg Infect Dis. 2018;24(1):114–117.
   PubMed Web of Science ®Google Scholar
• Towner JS, Pourrut X, Albariño CG, et al. Marburg virus infection detected in a common African bat. PLoS One. 2007;2(8):e764.
   PubMed Web of Science ®Google Scholar
• Amman BR, Carroll SA, Reed ZD, et al. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 2012;8(10):e1002877.
   PubMed Web of Science ®Google Scholar
• Olejnik J, Ryabchikova E, Corley RB, et al. Intracellular events and cell fate in filovirus infection. Viruses. 2011;3(8):1501–1531.
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Moore KA, Kelley NS, et al. Transmission of Ebola viruses: what we know and what we do not know. MBio. 2015;6(2):e00137.
   PubMed Web of Science ®Google Scholar
• Lau MSY, Dalziel BD, Funk S, et al. Spatial and temporal dynamics of superspreading events in the 2014-2015 West Africa Ebola epidemic. Proc Natl Acad Sci U S A. 2017;114(9):2337–2342.
   PubMed Web of Science ®Google Scholar
• Weingartl HM, Embury-Hyatt C, Nfon C, et al. Transmission of Ebola virus from pigs to non-human primates. Sci Rep. 2012;2:811.
   PubMed Web of Science ®Google Scholar
• Mafopa NG, Russo G, Guetiya Wadoum RE, et al. Seroprevalence of Ebola virus infection in Bombali District, Sierra Leone. J Public Health Afr. 2017;8(2):732.
   PubMed Web of Science ®Google Scholar
• Hoff NA, Mukadi P, Doshi RH, et al. Serologic markers for ebolavirus among healthcare workers in the Democratic Republic of the Congo. J Infect Dis. 2019;219(4):517–525.
   PubMed Web of Science ®Google Scholar
• Glynn JR, Bower H, Johnson S, et al. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infect Dis. 2017;17(6):645–653.
   PubMed Web of Science ®Google Scholar
• Timothy JWS, Hall Y, Akoi-Boré J, et al. Early transmission and case fatality of Ebola virus at the index site of the 2013-16 west African Ebola outbreak: a cross-sectional seroprevalence survey. Lancet Infect Dis. 2019;19(4):429-438.
   PubMed Web of Science ®Google Scholar
• Mulangu S, Alfonso VH, Hoff NA, et al. Serologic evidence of ebolavirus infection in a population with no history of outbreaks in the Democratic Republic of the Congo. J Infect Dis. 2018;217(4):529–537.
   PubMed Web of Science ®Google Scholar
• Mulangu S, Borchert M, Paweska J, et al. High prevalence of IgG antibodies to Ebola virus in the Efe pygmy population in the Watsa region, Democratic Republic of the Congo. BMC Infect Dis. 2016;16:263.
   PubMed Web of Science ®Google Scholar
• Schoepp RJ, Rossi CA, Khan SH, et al. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis. 2014;20(7):1176–1182.
   PubMed Web of Science ®Google Scholar
• Zapata JC, Salvato MS. Arenavirus variations due to host-specific adaptation. Viruses. 2013;5(1):241–278.
   PubMed Web of Science ®Google Scholar
• Pinsky BA, Sahoo MK, Sandlund J, et al. Analytical performance characteristics of the cepheid GeneXpert Ebola assay for the detection of Ebola virus. PLoS One. 2015;10(11):e0142216.
   PubMed Web of Science ®Google Scholar
• Akerlund E, Prescott J, Tampellini L. Shedding of Ebola virus in an asymptomatic pregnant woman. N Engl J Med. 2015;372(25):2467–2469.
   PubMed Web of Science ®Google Scholar
• Subissi L, Keita M, Mesfin S, et al. Ebola virus transmission caused by persistently infected survivors of the 2014-2016 outbreak in West Africa. J Infect Dis. 2018;218:S287-S291.
   PubMed Web of Science ®Google Scholar
• Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med. 2015;373(25):2448–2454.
   PubMed Web of Science ®Google Scholar
• Christie A, Davies-Wayne GJ, Cordier-Lassalle T, et al. Possible sexual transmission of Ebola virus - Liberia, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(17):479–481.
   PubMed Web of Science ®Google Scholar
• Sissoko D, Keïta M, Diallo B, et al. Ebola virus persistence in breast milk after no reported illness: a likely source of virus transmission from mother to child. Clin Infect Dis. 2017;64(4):513–516.
   PubMed Web of Science ®Google Scholar
• Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet. 2000;355(9222):2210–2215.
   PubMed Web of Science ®Google Scholar
• Bower H, Glynn JR. A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection. Sci Data. 2017;4:160133.
   PubMed Web of Science ®Google Scholar
• WHO. Laboratory diagnosis of Ebola virus disease. Geneva: WHO; 2014.
   Google Scholar
• WHO. Target Product Profile for Zaïre ebolavirus rapid, simple test to be used in the control of the Ebola outbreak in West Africa. 2014 [cited 2018 Aug 9]. Available from: http://www.who.int/medicines/publications/target-product-profile.pdf.
   Google Scholar
• Rieger T, Kerber R, El Halas H, et al. Evaluation of RealStar reverse transcription-polymerase chain reaction kits for filovirus detection in the laboratory and field. J Infect Dis. 2016;214(suppl 3):S243–S249.
   PubMedGoogle Scholar
• Nouvellet P, Garske T, Mills HL, et al. The role of rapid diagnostics in managing Ebola epidemics. Nature. 2015;528(7580):S109–16.
   PubMed Web of Science ®Google Scholar
• Cherpillod P, Schibler M, Vieille G, et al. Ebola virus disease diagnosis by real-time RT-PCR: a comparative study of 11 different procedures. J Clin Virol. 2016;77:9–14.
   PubMed Web of Science ®Google Scholar
• Strecker T, Palyi B, Ellerbrok H, et al. Field evaluation of capillary blood samples as a collection specimen for the rapid diagnosis of Ebola virus infection during an outbreak emergency. Clin Infect Dis. 2015;61(5):669–675.
   PubMed Web of Science ®Google Scholar
• Towner JS, Sealy TK, Khristova ML, et al. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008;4(11):e1000212.
   PubMed Web of Science ®Google Scholar
• Altona. Instructions for use RealStar® filovirus screen RT-PCR Kit 1.0. Altona Diagnostics, Hamburg, Germany. 2017.
   Google Scholar
• WHO. WHO emergency use assessment: RealStar® filovirus screen RT-PCR Kit 1.0. Geneva: WHO; 2015.
   Google Scholar
• Wang G, Zhang R, Han Y, et al. The evaluation of 7 commercial real-time PCR kits for Zaire ebolavirus using virus-like particle-encapsulated EBOV RNA. Diagn Microbiol Infect Dis. 2015;83(4):355–358.
   PubMed Web of Science ®Google Scholar
• BioFire Defense L. FilmArray ® BioThreat-E instructions for use. L. BioFire Defense, Editor. BioFire Defense, LLC, Salt Lake City, U.S 2016.
   Google Scholar
• Southern TR, Racsa LD, Albariño CG, et al. Comparison of FilmArray and quantitative real-time reverse transcriptase PCR for detection of zaire Ebolavirus from contrived and clinical specimens. J Clin Microbiol. 2015;53(9):2956–2960.
   PubMed Web of Science ®Google Scholar
• BioFire Defense L. FilmArray ® NGDS BT-E assay instructions for use. L. BioFire Defense, Editor. BioFire Defense, LLC, Salt Lake City, U.S 2016.
   Google Scholar
• Roche. LightMix® Ebola Zaire rRT-PCR test instruction manual. Roche Diagnostics, Basel, Switzerland 2018.
   Google Scholar
• Ltd, P.B.C. Ebola virus (Zaire type) nucleic acid detection kit (PCR fluorescent probe method). 2018 [cited 2018 Jul 18]. Available from: http://en.szprk.com/prod_view.aspx?TypeId=77&Id=183&FId=t3:77:3.
   Google Scholar
• NMRC. Ebola Zaire (EZ1) rRT-PCR (TaqMan®) assay instruction manual. NMRCof the U.S.Dept. of Defense, Silver Spring, Washington DC, U.S . 2014.
   Google Scholar
• de Wit E, Rosenke K, Fischer RJ, et al. Ebola laboratory response at the eternal love winning Africa campus, Monrovia, Liberia, 2014-2015. J Infect Dis. 2016;214(suppl 3):S169–S176.
   PubMedGoogle Scholar
• CDC. Ebola virus NP real-time RT-PCR assay - instructions for use. Atlanta: CDC; 2016.
   Google Scholar
• CDC. Ebola virus VP40 real-time RT-PCR assay - instructions for use. Atlanta: CDC; 2016.
   Google Scholar
• Xu C, Wang H, Jin H, et al. Visual detection of Ebola virus using reverse transcription loop-mediated isothermal amplification combined with nucleic acid strip detection. Arch Virol. 2016;161(5):1125–1133.
   PubMed Web of Science ®Google Scholar
• Kurosaki Y, Grolla A, Fukuma A, et al. Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method. J Clin Microbiol. 2010;48(7):2330–2336.
   PubMed Web of Science ®Google Scholar
• James AS, Todd S, Pollak NM, et al. Ebolavirus diagnosis made simple, comparable and faster than molecular detection methods: preparing for the future. Virol J. 2018;15(1):75.
   PubMedGoogle Scholar
• Magro L, Jacquelin B, Escadafal C, et al. Paper-based RNA detection and multiplexed analysis for Ebola virus diagnostics. Sci Rep. 2017;7(1):1347.
   PubMedGoogle Scholar
• Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004;78(8):4330–4341.
   PubMed Web of Science ®Google Scholar
• Moschos SA. Introducing EbolaCheck: potential for point-of-need infectious disease diagnosis. Expert Rev Mol Diagn. 2015;15(10):1237–1240.
   PubMed Web of Science ®Google Scholar
• Gallais F, Gay-Andrieu F, Picot V, et al. [Field assessment of the new rapid diagnostic test Ebola eZYSCREEN(R)]. Bull Soc Pathol Exot. 2017;110(1):38–48.
   PubMedGoogle Scholar
• Cross RW, Boisen ML, Millett MM, et al. Analytical validation of the ReEBOV antigen rapid test for point-of-care diagnosis of Ebola virus infection. J Infect Dis. 2016;214(suppl 3):S210–S217.
   PubMedGoogle Scholar
• Ikegami T, Niikura M, Saijo M, et al. Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein. Clin Diagn Lab Immunol. 2003;10(4):552–557.
   PubMedGoogle Scholar
• Boisen ML, Oottamasathien D, Jones AB, et al. Development of prototype filovirus recombinant antigen immunoassays. J Infect Dis. 2015;212(Suppl 2):S359–67.
   PubMedGoogle Scholar
• Jean Louis F, Huang JY, Nebie YK, et al. Implementation of broad screening with Ebola rapid diagnostic tests in Forécariah, Guinea. Afr J Lab Med. 2017;6(1):484.
   PubMed Web of Science ®Google Scholar
• Yen C-W, de Puig H, Tam JO, et al. Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses. Lab Chip. 2015;15(7):1638–1641.
   PubMed Web of Science ®Google Scholar
• W.H.O. WHO Emergency Use Assessment and Listing for EVD IVDs PUBLIC REPORT Product: SD Q Line Ebola Zaire Ag Number: EA 0021-020-002015.
   Google Scholar
• Yoshida R, Muramatsu S, Akita H, et al. Development of an immunochromatography assay (QuickNavi-Ebola) to detect multiple species of ebolaviruses. J Infect Dis. 2016;214(suppl 3):S185–S191.
   PubMedGoogle Scholar
• WHO. WHO emergency use assessment: Xpert® Ebola assay. Geneva: WHO; 2015.
   Google Scholar
• WHO. WHO emergency use assessment: FilmArray™ Biothreat-E. Geneva: WHO; 2015.
   Google Scholar
• Niedrig M, Schmitz H, Becker S, et al. First international quality assurance study on the rapid detection of viral agents of bioterrorism. J Clin Microbiol. 2004;42(4):1753–1755.
   PubMed Web of Science ®Google Scholar
• Erickson BR, Sealy TK, Flietstra T, et al. Ebola virus disease diagnostics, Sierra Leone: analysis of real-time reverse transcription-polymerase chain reaction values for clinical blood and oral swab specimens. J Infect Dis. 2016;214(suppl 3):S258–S262.
   PubMedGoogle Scholar
• Ellerbrok H, Jacobsen S, Patel P, et al. External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014-2016 Ebola outbreak in West Africa. PLoS Negl Trop Dis. 2017;11(5):e0005570.
   PubMed Web of Science ®Google Scholar
• Kerber R, Krumkamp R, Diallo B, et al. Analysis of diagnostic findings from the European mobile laboratory in Guéckédou, Guinea, March 2014 through March 2015. J Infect Dis. 2016;214(suppl 3):S250–S257.
   PubMed Web of Science ®Google Scholar
• Rosenke K, Adjemian J, Munster VJ, et al. Plasmodium parasitemia associated with increased survival in Ebola virus-infected patients. Clin Infect Dis. 2016;63(8):1026–1033.
   PubMed Web of Science ®Google Scholar
• Broadhurst MJ, Kelly JD, Miller A, et al. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 2015;386(9996):867–874.
   PubMed Web of Science ®Google Scholar
• Trombley AR, Wachter L, Garrison J, et al. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. 2010;82(5):954–960.
   PubMed Web of Science ®Google Scholar
• Logue CH, Lewis SM, Lansley A, et al. Case study: design and implementation of training for scientists deploying to Ebola diagnostic field laboratories in Sierra Leone: october 2014 to February 2016. Philos Trans R Soc Lond B Biol Sci. 2017;372(1721):20160299.
   PubMed Web of Science ®Google Scholar
• Faye O, Faye O, Soropogui B, et al. Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015. Euro Surveill. 2015;20(44).
   PubMedGoogle Scholar
• Walker NF, Brown C, Youkee D, et al. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Euro Surveill. 2015;20(12):21073.
   Google Scholar
• Vassall A, Siapka M, Foster N, et al. Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation. Lancet Glob Health. 2017;5(7):e710–e719.
   PubMed Web of Science ®Google Scholar
• FDA. Xpert® Ebola assay, instructions for use, for use under an Emergency Use Authorization (EUA) only. FDA, Silver Spring, Washington DC, U.S; 2015.
   Google Scholar
• Raftery P, Condell O, Wasunna C, et al. Establishing Ebola Virus Disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: impact on outbreak response, case management and laboratory systems strengthening. PLoS Negl Trop Dis. 2018;12(1):e0006135.
   PubMed Web of Science ®Google Scholar
• Semper AE, Broadhurst MJ, Richards J, et al. Performance of the GeneXpert Ebola assay for diagnosis of Ebola virus disease in sierra leone: a field evaluation study. PLoS Med. 2016;13(3):e1001980.
   PubMed Web of Science ®Google Scholar
• Van Den Bergh R, Chaillet P, Sow MS, et al. Feasibility of Xpert Ebola assay in medecins sans frontieres ebola program, Guinea. Emerg Infect Dis. 2016;22(2):210–216.
   PubMed Web of Science ®Google Scholar
• Pettitt J, Higgs E, Fallah M, et al. Assessment and optimization of the GeneXpert diagnostic platform for detection of Ebola virus RNA in seminal fluid. J Infect Dis. 2017;215(4):547–553.
   PubMed Web of Science ®Google Scholar
• Panning M, Laue T, Olschlager S, et al. Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis. 2007;196 Suppl 2(Suppl 2):S199–204.
   PubMedGoogle Scholar
• Jansen van Vuren P, Grobbelaar A, Storm N, et al. Comparative evaluation of the diagnostic performance of the prototype cepheid GeneXpert Ebola assay. J Clin Microbiol. 2016;54(2):359–367.
   PubMed Web of Science ®Google Scholar
• Mackay IM, Arden KE. Ebola virus in the semen of convalescent men. Lancet Infect Dis. 2015;15(2):149–150.
   PubMed Web of Science ®Google Scholar
• Loftis AJ, Quellie S, Chason K, et al. Validation of the cepheid GeneXpert for detecting Ebola virus in Semen. J Infect Dis. 2017;215(3):344–350.
   PubMed Web of Science ®Google Scholar
• Altona. Instructions for use RealStar® Zaire Ebolavirus RT-PCR Kit 1.0. Altona Diagnostics, Hamburg, Germany. 2017.
   Google Scholar
• Jääskeläinen AJ, Moilanen K, Aaltonen K, et al. Development and evaluation of a real-time EBOV-L-RT-qPCR for detection of Zaire ebolavirus. J Clin Virol. 2015;67:56–58.
   PubMed Web of Science ®Google Scholar
• Masum H, Lackman R, Bartleson K. Developing global health technology standards: what can other industries teach us? Global Health. 2013;9:49.
   PubMed Web of Science ®Google Scholar
• Cnops L, Van Den Eede P, Pettitt J, et al. Development, evaluation, and integration of a quantitative reverse-transcription polymerase chain reaction diagnostic test for ebola virus on a molecular diagnostics platform. J Infect Dis. 2016;214(suppl 3):S192–S202.
   PubMedGoogle Scholar
• Dedkov VG, Magassouba N, Safonova MV, et al. Sensitive multiplex real-time RT-qPCR assay for the detection of filoviruses. Health Secur. 2018;16(1):14–21.
   PubMed Web of Science ®Google Scholar
• Butler D. Speedy Ebola tests help contain Africa’s latest outbreak. Nature. 2018;558(7709):172.
   PubMedGoogle Scholar
• Negredo A, Palacios G, Vázquez-Morón S, et al. Discovery of an ebolavirus-like filovirus in europe. PLoS Pathog. 2011;7(10):e1002304.
   PubMed Web of Science ®Google Scholar
• WHO. Annual review of diseases prioritized under the Research and Development Blueprint. Geneva: WHO; 2018.
   Google Scholar
• Simulundu E, Mweene AS, Changula K, et al. Lujo viral hemorrhagic fever: considering diagnostic capacity and preparedness in the wake of recent Ebola and Zika virus outbreaks. Rev Med Virol. 2016;26(6):446–454.
   PubMed Web of Science ®Google Scholar
• Benzine JW, Brown KM, Agans KN, et al. Molecular diagnostic field test for point-of-care detection of Ebola virus directly from blood. J Infect Dis. 2016;214(suppl 3):S234–S242.
   PubMedGoogle Scholar
• Kost GJ. Molecular and point-of-care diagnostics for Ebola and new threats: national POCT policy and guidelines will stop epidemics. Expert Rev Mol Diagn. 2018;18(7):657–673.
   PubMed Web of Science ®Google Scholar
• Pellecchia U, Crestani R, Decroo T, et al. Social consequences of Ebola containment measures in Liberia. PLoS One. 2015;10(12):e0143036.
   PubMed Web of Science ®Google Scholar
• Editor T. Ebola in west Africa: gaining community trust and confidence. Lancet. 2014;383(9933):1946.
   Web of Science ®Google Scholar
• Broadhurst MJ, Semper A, Bailey D, et al. ReEBOV antigen rapid test kit for Ebola - authors’ reply. Lancet. 2015;386(10010):2255–2256.
   PubMed Web of Science ®Google Scholar
• Olschlager S, Hess M. ReEBOV antigen rapid test kit for Ebola. Lancet. 2015;386(10010):2254.
   PubMedGoogle Scholar
• Urassa W, Meurant R, Wood D. ReEBOV antigen rapid test kit for Ebola. Lancet. 2015;386(10010):2253–2254.
   PubMedGoogle Scholar
• Boisen ML, Cross RW, Hartnett JN, et al. Field validation of the ReEBOV antigen rapid test for point-of-care diagnosis of Ebola virus infection. J Infect Dis. 2016;214(suppl 3):S203–S209.
   PubMedGoogle Scholar
• WHO. WHO emergency use assessment: ReEBOV™ antigen rapid test kit. Geneva: WHO; 2015.
   Google Scholar
• FDA. Historical information about device emergency use authorizations. 2018 [cited 2018 Sep 3]. Available from: https://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm418778.htm.
   Google Scholar
• VanSteelandt A, Aho J, Franklin K, et al. Operational evaluation of rapid diagnostic testing for Ebola Virus Disease in Guinean laboratories. PLoS One. 2017;12(11):e0188047.
   PubMed Web of Science ®Google Scholar
• Phan JC, Pettitt J, George JS, et al. Lateral flow immunoassays for Ebola virus disease detection in Liberia. J Infect Dis. 2016;214(suppl 3):S222–S228.
   PubMedGoogle Scholar
• Kost GJ, Ferguson W, Truong A-T, et al. Molecular detection and point-of-care testing in Ebola virus disease and other threats: a new global public health framework to stop outbreaks. Expert Rev Mol Diagn. 2015;15(10):1245–1259.
   PubMed Web of Science ®Google Scholar
• Du Y, Pothukuchy A, Gollihar JD, et al. Coupling sensitive nucleic acid amplification with commercial pregnancy test strips. Angew Chem Int Ed Engl. 2017;56(4):992–996.
   PubMed Web of Science ®Google Scholar
• Hoenen T, Groseth A, Rosenke K, et al. Nanopore sequencing as a rapidly deployable Ebola outbreak tool. Emerg Infect Dis. 2016;22(2):331–334.
   PubMed Web of Science ®Google Scholar
• Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345(6202):1369–1372.
   PubMed Web of Science ®Google Scholar
• Dudas G, Carvalho LM, Bedford T, et al. Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature. 2017;544(7650):309–315.
   PubMed Web of Science ®Google Scholar
• Capobianchi MR, Gruber CEM, Carletti F, et al. Molecular signature of the ebola virus associated with the fishermen community outbreak in Aberdeen, Sierra Leone, in February 2015. Genome Announc. 2015;3(5).
   Google Scholar
• Carroll MW, Matthews DA, Hiscox JA, et al. Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa. Nature. 2015;524(7563):97–101.
   PubMed Web of Science ®Google Scholar
• Hoenen T, Safronetz D, Groseth A, et al. Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences. Science. 2015;348(6230):117–119.
   PubMed Web of Science ®Google Scholar
• Tong Y-G, Shi W-F, Liu D, et al. Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone. Nature. 2015;524(7563):93–96.
   PubMed Web of Science ®Google Scholar
• Reusken C, Niedrig M, Pas S, et al. Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. J Clin Virol. 2015;62:124–134.
   PubMed Web of Science ®Google Scholar
• Gardy JL, Loman NJ. Towards a genomics-informed, real-time, global pathogen surveillance system. Nat Rev Genet. 2018;19(1):9–20.
   PubMed Web of Science ®Google Scholar
• Pankhurst LJ, Del Ojo Elias C, Votintseva AA, et al. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med. 2016;4(1):49–58.
   PubMed Web of Science ®Google Scholar
• Hamers RL, Paredes R. Next-generation sequencing and HIV drug resistance surveillance. Lancet HIV. 2016;3(12):e553–e554.
   PubMed Web of Science ®Google Scholar
• Greninger AL, Naccache SN, Federman S, et al. Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Genome Med. 2015;7:99.
   PubMed Web of Science ®Google Scholar
• Schmidt K, Mwaigwisya S, Crossman LC, et al. Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing. J Antimicrob Chemother. 2017;72(1):104–114.
   PubMed Web of Science ®Google Scholar
• Quick J, Loman NJ, Duraffour S, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature. 2016;530(7589):228–232.
   PubMed Web of Science ®Google Scholar
• Keller MW, Rambo-Martin BL, Wilson MM, et al. Direct RNA sequencing of the coding complete influenza A virus genome. Sci Rep. 2018;8(1):14408.
   PubMedGoogle Scholar
• Brinkmann A, Ergünay K, Radonić A, et al. Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics. PLoS Negl Trop Dis. 2017;11(11):e0006075.
   PubMed Web of Science ®Google Scholar
• Koehler JW, Hall AT, Rolfe PA, et al. Development and evaluation of a panel of filovirus sequence capture probes for pathogen detection by next-generation sequencing. PLoS One. 2014;9(9):e107007.
   PubMed Web of Science ®Google Scholar
• Altan E, Aiemjoy K, Phan TG, et al. Enteric virome of Ethiopian children participating in a clean water intervention trial. PLoS One. 2018;13(8):e0202054.
   PubMed Web of Science ®Google Scholar
• Koch B, Schult-Dietrich P, Büttner S, et al. Lectin affinity plasmapheresis for middle east respiratory syndrome-coronavirus and marburg virus glycoprotein elimination. Blood Purif. 2018;46(2):126–133.
   PubMed Web of Science ®Google Scholar
• Rosenstierne MW, Karlberg H, Bragstad K, et al. Rapid bedside inactivation of Ebola virus for safe nucleic acid tests. J Clin Microbiol. 2016;54(10):2521–2529.
   PubMed Web of Science ®Google Scholar
• Ostromohov N, Schwartz O, Bercovici M. Focused upon hybridization: rapid and high sensitivity detection of DNA using isotachophoresis and peptide nucleic acid probes. Anal Chem. 2015;87(18):9459–9466.
   PubMed Web of Science ®Google Scholar
• Coarsey CT, Esiobu N, Narayanan R, et al. Strategies in Ebola virus disease (EVD) diagnostics at the point of care. Crit Rev Microbiol. 2017;43(6):779–798.
   PubMed Web of Science ®Google Scholar
• Yu JS, Liao HX, Gerdon AE, et al. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor. J Virol Methods. 2006;137(2):219–228.
   PubMed Web of Science ®Google Scholar
• Seymour E, Daaboul GG, Zhang X, et al. DNA-directed antibody immobilization for enhanced detection of single viral pathogens. Anal Chem. 2015;87(20):10505–10512.
   PubMed Web of Science ®Google Scholar
• Daaboul GG, Freedman DS, Scherr SM, et al. Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses. PLoS One. 2017;12(6):e0179728.
   PubMed Web of Science ®Google Scholar
• Carter EP, Seymour EÇ, Scherr SM, et al. Visualizing ebolavirus particles using single-particle interferometric reflectance imaging sensor (SP-IRIS). Methods Mol Biol. 2017;1628:259–270.
   PubMedGoogle Scholar
• Scherr SM, Freedman DS, Agans KN, et al. Disposable cartridge platform for rapid detection of viral hemorrhagic fever viruses. Lab Chip. 2017;17(5):917–925.
   PubMed Web of Science ®Google Scholar
• Liang H, Zhou Z, Zhang S, et al. Identification of Ebola virus microRNAs and their putative pathological function. Sci China Life Sci. 2014;57(10):973–981.
   PubMed Web of Science ®Google Scholar
• Correia CN, Nalpas NC, McLoughlin KE, et al. Circulating microRNAs as potential biomarkers of infectious disease. Front Immunol. 2017;8:118.
   PubMed Web of Science ®Google Scholar
• Chen Z, Liang H, Chen X, et al. An Ebola virus-encoded microRNA-like fragment serves as a biomarker for early diagnosis of Ebola virus disease. Cell Res. 2016;26(3):380–383.
   PubMed Web of Science ®Google Scholar
• Teng Y, Wang Y, Zhang X, et al. Systematic genome-wide screening and prediction of microRNAs in EBOV during the 2014 Ebolavirus outbreak. Sci Rep. 2015;5:9912.
   PubMed Web of Science ®Google Scholar
• Duy J, Honko AN, Altamura LA, et al. Virus-encoded miRNAs in Ebola virus disease. Sci Rep. 2018;8(1):6480.
   PubMedGoogle Scholar